Celltrion

Patient populations eligible for subcutaneous infliximab treatment – a review of RWE and clinical data

November 28 – 9.10 – 9.40 Satellite Symposia 7

Speakers:

• Prof. Marte L. Høivik, Oslo University Hospital, Norway
• Dr. Julia Husman, University Hospital Dresden, Germany
• Dr. Stephan L. Haas, Karolinska University Hospital, Sweden